Hung D. Nguyen

发表

Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice

J. Pidala, D. McDonald, Chen Liu, 2015, PloS one.

Ceramide synthesis regulates T cell activity and GVHD development.

H. Stark, B. Ogretmen, Yingjun Chang, 2017, JCI insight.

PIM‐2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity

S. Mehrotra, E. Hill, A. Kraft, 2018, The Journal of clinical investigation.

T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice

Junfei Jin, C. Anasetti, Chen Liu, 2016, The Journal of Immunology.

Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells

G. Hardiman, M. Nishimura, S. Mehrotra, 2019, The Journal of Biological Chemistry.

Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease

A. Alawieh, C. Atkinson, S. Tomlinson, 2020, Clinical Cancer Research.

Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.

C. Xia, Steven D. Schutt, Jianing Fu, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Stabilization of Foxp3 by Targeting JAK2 Enhances Efficacy of CD8 Induced Regulatory T Cells in the Prevention of Graft-versus-Host Disease

Chen Liu, Hung D. Nguyen, D. Bastian, 2018, The Journal of Immunology.

Inducible T-Cell Co-Stimulator Impacts Chronic Graft-Versus-Host Disease by Regulating Both Pathogenic and Regulatory T Cells

Jinsam Chang, W. Suh, Fang-ping Chen, 2018, Front. Immunol..

Vitamin C stabilizes CD8+ iTregs and enhances their therapeutic potential in controlling murine GVHD and leukemia relapse.

Hung D. Nguyen, D. Bastian, Yongxia Wu, 2019, Blood advances.

CD8+ Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4+ Tregs in mice

Junfei Jin, C. Anasetti, Chen Liu, 2016, Oncoimmunology.

MicroRNA-31 regulates T-cell metabolism via HIF1α and promotes chronic GVHD pathogenesis in mice

K. Helke, Zhenwu Luo, L. Schnapp, 2022, Blood advances.

Inhibition of the IRE-1α/XBP-1 pathway prevents chronic GVHD and preserves the GVL effect in mice.

K. Helke, J. D. Del Valle, C. Hu, 2018, Blood advances.

Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells.

D. Fairlie, B. Ogretmen, C. Atkinson, 2018, JCI insight.

Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease.

S. Mehrotra, N. Maulik, B. Ogretmen, 2019, The Journal of clinical investigation.

The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease

K. Helke, Y. Ben-David, W. Cui, 2022, The Journal of clinical investigation.

Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice.

S. Mehrotra, P. Chakraborty, Chen Liu, 2019, Blood.

Interleukin‐23 receptor signaling by interleukin‐39 potentiates T cell pathogenicity in acute graft‐versus‐host disease

E. Bartee, M. Sofi, Steven D. Schutt, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Lysosomal Acid Lipase Is Required for Donor T Cells to Induce Graft-versus-Host Disease

H. Du, Taylor Ticer, Hung D. Nguyen, 2020, Cell reports.

Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis

Y. Peterson, S. Mehrotra, B. Ogretmen, 2022, Cell reports.

Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation

J. Singer, J. Pidala, C. Anasetti, 2018, Proceedings of the National Academy of Sciences.

T-Cell Metabolism in Hematopoietic Cell Transplantation

Hung D. Nguyen, D. Bastian, Xue-Zhong Yu, 2018, Front. Immunol..

MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice.

Junfei Jin, Chen Liu, C. Xia, 2015, Blood.

MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice.

B. Blazar, Yingjun Chang, R. Flynn, 2018, Blood.